Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices.
In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.
Patients aged 18 years and older.
Undergoing cholecystectomy.
Surgery performed in public or private hospitals in Algeria.
Surgery performed from January 1, 2025, to June 30, 2025.
Patients younger than 18 years.
Patients refusing to participate.
Cholecystectomy performed for Gallbladder cancer.
Cholecystectomy performed outside the inclusion period.
The study population consists of patients aged 18 years and older who undergo cholecystectomy for benign gallbladder diseases in Algeria. This includes patients who have their gallbladders removed due to conditions such as gallstones, cholecystitis, biliary dyskinesia and any other benign pathology
Cohort
Prospective
Not listed
Evaluate the 30-day mortality and morbidity
Evaluation of rate of mortality and morbidity at 30 day
factors associated with 30-day morbidity and mortality
determinants of the occurence of complications and mortality on or before 30 day in postopérative period
estimate the incidence of incidental gallbladder cancer discovered during cholecystectomy in Algeria.
estimate the incidence of bile duct injuries following cholecystectomy for benign diseases
assess surgical practices related to cholecystectomy in Algeria.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
